Clinical Observation: Assessment of Factors Associated with the Refusal or Termination of Treatment in Patients with Breast Cancer
https://doi.org/10.37174/2587-7593-2023-6-1-80-87
Abstract
The study analyzed the clinical observation of the psychological characteristics of a woman diagnosed with breast cancer, who refused part of the proposed therapy, and had no contraindications to start special treatment.
Patient Yu.F., born in 1953, diagnosis: cancer of the right breast T1NxM0 ЭР(95 %), ПР(15 %), Her2neu(0), Ki67 (5 %), refused for personal reasons from the surgical treatment proposed at the 1st stage (a written refusal was taken), in connection with which a course of hormone therapy was prescribed, a course of remote radiation therapy according to a radical program. When assessing the psychological profile of the patient, the data obtained demonstrate the presence of paradoxical hyperprotection in the patient who refused part of the treatment. Her psychological profile is similar to the psychological characteristics of women with breast cancer, whose course of the disease ended in death. In a study conducted in 2021, data were obtained on women with a negative outcome of the disease (death), who were convinced of their own luck and in the ability to control what was happening, used a wide range of coping strategies, were more resilient, are optimistic and had a pronounced internality in comparison with women in whom the disease went into stable remission.
About the Authors
A. I. KuznetsovaRussian Federation
64, Vorovsky Str., Chelyabinsk, 454092; 36, Lenin Ave., Tomsk, 634050
Competing Interests:
Not declared
Ya. N. Pakhomova
Russian Federation
36, Lenin Ave., Tomsk, 634050; 129, Kashirin Brothers Str., Chelyabinsk, 454001
Competing Interests:
Not declared
D. A. Tsiring
Russian Federation
36, Lenin Ave., Tomsk, 634050; 58, Rabotnits Str., Chelyabinsk, 454084
Competing Interests:
Not declared
A. V. Vazhenin
Russian Federation
64, Vorovsky Str., Chelyabinsk, 454092
Competing Interests:
Not declared
I. V. Ponomareva
Russian Federation
36, Lenin Ave., Tomsk, 634050; 58, Rabotnits Str., Chelyabinsk, 454084; 129, Kashirin Brothers Str., Chelyabinsk, 454001
Competing Interests:
Not declared
M. N. Mironchenko
Russian Federation
64, Vorovsky Str., Chelyabinsk, 454092; 36, Lenin Ave., Tomsk, 634050
Competing Interests:
Not declared
M. A. Demchuk
Russian Federation
36, Lenin Ave., Tomsk, 634050; 58, Rabotnits Str., Chelyabinsk, 454084; 129, Kashirin Brothers Str., Chelyabinsk, 454001
Competing Interests:
Not declared
Yu. O. Gladkov
Russian Federation
36, Lenin Ave., Tomsk, 634050; 58, Rabotnits Str., Chelyabinsk, 454084; 129, Kashirin Brothers Str., Chelyabinsk, 454001
Competing Interests:
Not declared
T. S. Novikova
Russian Federation
64, Vorovsky Str., Chelyabinsk, 454092
Competing Interests:
Not declared
References
1. Clinical Recommendations. Breast Cancer (Approved by the Scientific and Practical Council of the Ministry of Health of the Russian Federation). 2021. 127 p. (In Russian).
2. Meyer F, Fortin A, Wang CS, et al. Predictors of severe acute and late toxicities in patients with localized head-and-neck cancer treated with radiation therapy. Int J Radiat Oncol Biol Phys. 2012 Mar 15;82(4):1454-62. DOI: 10.1016/j.ijrobp.2011.04.022.
3. Na Suh W, Kong KA, Han Y, et al. Risk factors associated with treatment refusal in lung cancer. Thorac Cancer. 2017;8:443-50. DOI: 10.1111/1759-7714.12461.
4. Chen S.J, Kung P.-T, Huang K.H, et al. Characteristics of the delayed or refusal therapy in breast cancer patients: A longitudinal population-based study in Taiwan. PLoS ONE. 2015;10:e0131305. DOI: 10.1371/journal.pone.0131305.
5. Chiang TY, Wang CH, Lin YF, et al. Colorectal cancer in Taiwan: A case-control retrospective analysis of the impact of a case management program on refusal and discontinuation of treatment. J Adv Nurs. 2018;74:395-406. DOI: 10.1111/jan.13443.
6. Mehta RS, Lenzner D, Argiris A. Race and health disparities in patient refusal of surgery for early-stage non-small cell lung cancer: A SEER cohort study. Ann Surg Oncol. 2011;19:722-7. DOI: 10.1245/s10434-011-2087-3.
7. Dispinzieri M, La Rocca E, Meneghini E, et al. Discontinuation of hormone therapy for elderly breast cancer patients after hypofractionated whole-breast radiotherapy. Med Oncol. 2018;35:107. DOI: 10.1007/s12032-018-1165-9.
8. Eichler M, Singer S, Janni W, et al. Pretreatment quality of life, performance status and their relation to treatment discontinuation and treatment changes in high-risk breast cancer patients receiving chemotherapy: Results from the prospective randomized ADEBAR trial. Breast Cancer. 2016;24:319-25. DOI: 10.1007/s12282-016-0706-3.
9. Freedman RA, Fedewa SA, Punglia RS, et al. Factors associated with radiation therapy incompletion for patients with early-stage breast cancer. Breast Cancer Res Treat. 2015;155:187-99. DOI: 10.1007/s10549-015-3660-4.
10. Honecker F, Wedding U, Kallischnigg G, et al. Risk factors for unplanned discontinuation of scheduled treatment in elderly patients with castration-resistant prostate cancer: Results of the IBuTu study. J Cancer Res Clin Oncol. 2018;144:571-7. DOI: 10.1007/s00432-017-2577-1.
11. Sethi RA, Stamell EF, Price L, et al. Head and neck radiotherapy compliance in an underserved patient population. Laryngoscope. 2010;120:1336-41. DOI: 10.1002/lary.20963.
12. World Health Organization. International Statistical Classification of Diseases and Related Health Problems. 10th Revision ed. 2010. [(accessed on 6 November 2020)]. URL: https://www.who.int/classifications/icd/ICD10Volume2_en_2010.
13. Tsiring DA, Sergeenko EA, Ponomareva IV, et al. Psychological Predictors of Early Access for a Doctor among Women with Primary Luminal Breast Cancer. Siberian Journal of Psychology. 2022;(84):126-42. (In Russian). DOI: 10.17223/17267080/84/7.
Review
For citations:
Kuznetsova A.I., Pakhomova Ya.N., Tsiring D.A., Vazhenin A.V., Ponomareva I.V., Mironchenko M.N., Demchuk M.A., Gladkov Yu.O., Novikova T.S. Clinical Observation: Assessment of Factors Associated with the Refusal or Termination of Treatment in Patients with Breast Cancer. Journal of oncology: diagnostic radiology and radiotherapy. 2023;6(1):80-87. (In Russ.) https://doi.org/10.37174/2587-7593-2023-6-1-80-87